O

Oramed Pharmaceuticals
D

ORMP

2.36000
USD
-0.01
(-0.42%)
Market Open
Volume
1,565
EPS
-0
Div Yield
-
P/E
21
Market Cap
95,136,483
Related Instruments
    A
    ARDX
    -0.11500
    (-2.39%)
    4.70000 USD
    D
    DVAX
    0.160
    (1.26%)
    12.880 USD
    K
    KALV
    0.01500
    (0.18%)
    8.37000 USD
    O
    OGEN
    -0.00450
    (-1.25%)
    0.35550 USD
    V
    VBLT
    -0.01140
    (-6.65%)
    0.16000 USD
    V
    VKTX
    -0.800
    (-1.89%)
    41.470 USD
    More
News

Title: Oramed Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.